Birzeit Pharmaceuticals Company (PEX: BPC)

Market Cap	103.01M
Revenue (ttm)	27.99M
Net Income (ttm)	1.92M
Shares Out	38.76M
EPS (ttm)	0.05
PE Ratio	53.02
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Apr 24, 2024

Volume	1,594
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About BPC

Birzeit Pharmaceuticals Company manufactures and trades in various medicines in the Palestinian Authority. The company offers its products in various therapeutic fields comprising alimentary system, cardio-vascular system, muscolo-skeletal system, endocrines, central nervous system, genito-urinary system, obstetrics and gynecology, infections, dermatological preparations, ophthalmic drugs, respiratory system, and nutrition and metabolism, as well as ear, nose, and oropharynx. It also provides OTC products, such as multivitamins and minerals, an...

• Industry: Pharmaceutical Preparations
• Founded: 1973
• Employees: 300
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: BPC

Financial Performance

In 2023, BPC's revenue was $43.13 million, a decrease of -8.31% compared to the previous year's $47.03 million. Earnings were $6.12 million, a decrease of -23.05%.

Financial numbers in USD